Alpha Teknova, Inc.

TKNO · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
66
SEC Filings

Business Summary

Facilities for specific information about our commercial, office, manufacturing, and warehouse space. Ite m 3. Legal Proceedings. We are not a party to any material legal proceedings at this time. From time to time, we may become involved in various legal proceedings that arise in the ordinary course of business. For example, we may in the future become involved in legal proceedings relating to customers, employees, suppliers, competitors, government agencies, or others. We will evaluate any cla...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTKNOdiscussed_in_filing Cybersecurity
topic_mentionTKNOdiscussed_in_filing Cybersecurity
topic_mentionTKNOdiscussed_in_filing Sovereign & Government
topic_mentionTKNOdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001850902-26-000002EDGAR61K words
2025-03-072024-12-310000950170-25-035705EDGAR—
2024-03-272023-12-310000950170-24-036624EDGAR—
2023-03-302022-12-310000950170-23-010926EDGAR—
2022-03-182021-12-310000950170-22-004176EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001193125-25-272321EDGAR22K words
2025-08-082025-06-300000950170-25-105825EDGAR—
2025-05-092025-03-310000950170-25-068050EDGAR—
2024-11-082024-09-300000950170-24-124159EDGAR—
2024-08-132024-06-300000950170-24-096441EDGAR—
2024-05-132024-03-310000950170-24-058827EDGAR—
2023-11-132023-09-300000950170-23-063053EDGAR—
2023-08-112023-06-300000950170-23-041875EDGAR—
2023-05-112023-03-310000950170-23-021313EDGAR—
2022-11-142022-09-300000950170-22-024641EDGAR—
2022-08-112022-06-300000950170-22-016861EDGAR—
2022-05-122022-03-310000950170-22-009650EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076592EDGAR5K words
2025-11-060001193125-25-269488EDGAR—
2025-08-070000950170-25-105005EDGAR—
2025-06-230000950170-25-089004EDGAR—
2025-05-080000950170-25-067005EDGAR—
2025-03-040000950170-25-031995EDGAR—
2024-11-070000950170-24-123359EDGAR—
2024-08-130000950170-24-096188EDGAR—
2024-07-120000950170-24-083216EDGAR—
2024-07-090000950170-24-082477EDGAR—

66 total filings indexed. 39 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE ICCC — IMMUCELL CORP /DE/

Company Identity

CIK0001850902
TickerTKNO
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9cd1d7121dc1ee142720a13382dcdfeb038047652326fbc9bb030650eae51c40
parent: a2735f336fb775550788f79c08f8622a350f4490ba979b2aa87b85b9ab415fb7
content hash: 9b2a4c045602561cb6eb6ad925b31829b52fd769f4d0593a62613c44d9337c26
signed: 2026-04-13T04:47:48.790Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf